| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
10T1/2 |
Treatment: sictrl; Background cell line: C3H/HeN; |
Permissive
Robust
|
Mus musculus |
GSE40369
...
|
MA0083.3
|
| SRF |
ILC2 (type 2 Innate lympoid cells) |
Treatment: siMed23; Background cell line: C3H/HeN; Genotype: knockdown Med23; |
Permissive
Robust
|
Mus musculus |
GSE40369
...
|
MA0083.3
|
| SRF |
induced pluripotent stem cells |
Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0083.3
|
| SRF |
induced pluripotent stem cells |
Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0083.3
|
| SRF |
induced pluripotent stem cells |
Passage: 25 days; Genotype: Overexpression SRF; Treatment: pMSCV mediated virus; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0083.3
|
| SRF |
induced pluripotent stem cells |
Passage: 25 days; Genotype: Overexpression SRF, caMKL1 blocked; Treatment: pMSCV mediated virus; |
Permissive
Robust
|
Mus musculus |
GSE120399
...
|
MA0083.3
|
| SRF |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BGE
|
MA0083.3
|
| SRF |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BIV
|
MA0083.3
|
| SRF |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BLK
|
MA0083.3
|
Showing 10 records in page 4
from 6 pages